INOVIO Completes BLA Submission for INO-3107, a DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously rece...

November 04, 2025 | Tuesday | News
Cryoport Sets New Industry Benchmark as First Supply Chain Solutions Provider Certified Under ISO 21973

First Global Supply Chain Solutions Company to Achieve ISO 21973 Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards ...

October 31, 2025 | Friday | News
Invivyd Receives FDA Clearance to Advance REVOLUTION Program with Phase 3 DECLARATION and LIBERTY Trials for COVID Prevention

The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clini...

October 07, 2025 | Tuesday | News
European Commission Approves Lilly’s Kisunla™ (donanemab) for Early Symptomatic Alzheimer’s Disease

Approved for use in the earliest symptomatic stages, Kisunla is the only once-monthly amyloid plaque–targeting therapy with evidence supporting tre...

September 26, 2025 | Friday | News
Remedium Bio and Eli Lilly Enter Multi-Target Gene Therapy Collaboration in Type 2 Diabetes and Obesity

Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and...

September 24, 2025 | Wednesday | News
Monte Rosa Therapeutics and Novartis Expand Collaboration with New $120M Upfront Deal to Develop Novel Immunology Degraders

Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s...

September 16, 2025 | Tuesday | News
Galimedix Completes Phase 1 Trial of Oral GAL-101, Advancing Toward Phase 2 in Alzheimer’s Disease

GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administration GAL-101 effectively crosses the blood-br...

September 15, 2025 | Monday | News
InnoCare Pharma Wins Singapore HSA Approval for HIBRUKA Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA ...

September 09, 2025 | Tuesday | News
How Does A PCR Technique Detect The Monkeypox Virus?

  According to recent statistics, the WHO (World Health Organization) has conducted an assessment of mpox cases in Africa, which showed that, as of 2...

September 03, 2025 | Wednesday | News
Santhera Pharmaceuticals Signs Exclusive Deal with Ikris Pharma Network to Distribute AGAMREE® in India

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAM...

September 01, 2025 | Monday | News
Atropos Health and Novartis Partner to Harness AI for Faster Rare Disease Diagnosis

-Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, announced a collaboration wit...

August 19, 2025 | Tuesday | News
Anbio Launches Chikungunya Rapid Test and Ultra-Fast PCR System to Strengthen Global Outbreak Response

Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible ...

August 11, 2025 | Monday | News
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million All-Cash Deal

SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on medicines for rare diseases and medical emergencies, and ...

August 06, 2025 | Wednesday | News
VedTechBio Advances AI Drug Discovery with RxAgentAI™, Joins Forces with AlphaMeld to Accelerate Therapeutic Development

VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug di...

July 31, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close